Cas enzymes that place viral DNA into CRISPR region rely on flexibility and shape – Science Daily
Genetic Engineering & Biotechnology News |
Cas enzymes that place viral DNA into CRISPR region rely on flexibility and shape
Science Daily These proteins, which were recently used to encode a movie in the CRISPR regions of bacterial genomes, rely on the unique flexibility of the CRISPR DNA to recognize it as the site where viral DNA should be inserted, ensuring that “memories” of prior … CRISPR Structure Data Reveals How Cas Enzymes Choose TargetGenetic Engineering & Biotechnology News Cas1-Cas2 Integrase Structures Enable Bacteria to Adapt to New VirusesGenomeWeb |
Gizmodo |
Genetically Engineering Nature Will Be Way More Complicated Than We Thought
Gizmodo For more than half a century, scientists have dreamed of harnessing an odd quirk of nature— “selfish genes,” which bypass the normal 50/50 laws of inheritance and force their way into offspring—to engineer entire species. A few years ago, the advent … |
Phys.Org |
Researchers discover how CRISPR proteins find their target
Phys.Org These proteins, which were recently used to encode a movie in the CRISPR regions of bacterial genomes, rely on the unique flexibility of the CRISPR DNA to recognize it as the site where viral DNA should be inserted, ensuring that “memories” of prior … Cas1-Cas2 Integrase Structures Enable Bacteria to Adapt to New VirusesGenomeWeb |
Science Daily |
Innate reaction of hematopoietic stem cells to severe infections …
Science Daily For the first time, researchers have shown that hematopoietic stem cells detect infectious agents themselves and begin to divide – that is, without signals from … |
Philadelphia magazine |
Spark Therapeutics Gene Therapy for Blindness Moves Forward With FDA
Philadelphia magazine There’s a greater chance now than ever before that the Food and Drug Administration’s first two approved gene therapies will both come from Philadelphia. This week, the FDA granted “priority review” status to Spark Therapeutics’ biologics license … |
Philadelphia magazine |
Spark Therapeutics Gene Therapy for Blindness Moves Forward With FDA
Philadelphia magazine There’s a greater chance now than ever before that the Food and Drug Administration’s first two approved gene therapies will both come from Philadelphia. This week, the FDA granted “priority review” status to Spark Therapeutics’ biologics license … |